Fresolimumab (TGFB/TGF beta) - Research Grade Biosimilar
Selected Variant
10-195
Size: 0.1 mg
Product Specifications
Background
Fresolimumab has been used in trials studying the treatment of Primary Brain Tumors, Metastatic Breast Cancer, Diffuse Systemic Sclerosis, Pleural Malignant Mesothelioma, and Primary Focal Segmental Glomerulosclerosis.
Immunogen
Homo sapiens / TGFB/TGF beta [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
GC-1008
Price
Sign In for Pricing
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC882299-100 1x 100 µL
Estrogen Receptor, alpha (Marker of Estrogen Dependence) (ESR1/2299R), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471993-100 1x 100 µL
Cytokeratin 20 (KRT20) (Colorectal Epithelial Marker) (KRT20/1993), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC681130-100 1x 100 µL
MUC18 / Mucin 18 / CD146 (MUC18/1130), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC881201-100 1x 100 µL
Neurofilament (H+L) (RT-97 + NR-4), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471757-100 1x 100 µL
CELA3B / ELA3B (Pancreatic Function Marker) (CELA3B/1757), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040812-100 1x 100 µL
Tyrosinase (OCA1/812), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details